These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 23653984

  • 1. Early diagnosis of an allergic reaction to cisatracurium.
    Goikoetxea MJ, Lafuente A, de la Borbolla JM, Moncada R, Sanz ML, Gastaminza G.
    J Investig Allergol Clin Immunol; 2013; 23(1):69-71. PubMed ID: 23653984
    [No Abstract] [Full Text] [Related]

  • 2. Cisatracurium and atracurium as antigens.
    Fisher MM.
    Anaesth Intensive Care; 1999 Aug; 27(4):369-70. PubMed ID: 10470390
    [Abstract] [Full Text] [Related]

  • 3. Possible underestimation of the relative incidence of anaphylactic reactions to benzylisoquinoline neuromuscular blocking agents.
    Lagneau F, Corda B, Marty J.
    Eur J Anaesthesiol; 2003 Jul; 20(7):577-8. PubMed ID: 12884994
    [No Abstract] [Full Text] [Related]

  • 4. Anaphylactic reaction after cisatracurium.
    Clendenen SR, Harper JV, Wharen RE, Guarderas JC.
    Anesthesiology; 1997 Sep; 87(3):690-2. PubMed ID: 9316977
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Cisatracurium induces mast cell activation and pseudo-allergic reactions via MRGPRX2.
    Che D, Rui L, Cao J, Wang J, Zhang Y, Ding Y, Zhao T, Ma P, An H, Gao Z, Zhang T.
    Int Immunopharmacol; 2018 Sep; 62():244-250. PubMed ID: 30032049
    [Abstract] [Full Text] [Related]

  • 13. [Type IV anaphylactic reaction and ST-elevation acute coronary syndrome due to coronary vasospasm secondary to administration of cisatracurium].
    Benítez Morillo MF, Casares Vivas M, Tejada Ruiz FJ, Narváez Bermejo JM.
    Med Intensiva; 2008 Sep; 32(5):260-1. PubMed ID: 18570839
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Phlebitis as a consequence of peripheral intravenous administration of cisatracurium besylate in critically ill patients.
    Meeder AM, van der Steen MS, Rozendaal A, van Zanten AR.
    BMJ Case Rep; 2016 Oct 03; 2016():. PubMed ID: 27698008
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.